Piermont Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-570	Closed	-$532K	–	272
2017 Q2	$532K	Sell	570 -102	-15%	-$95.2K	0.15%	223
2017 Q1	$639K	Buy	+672	New	+$639K	0.15%	211
2015 Q3	–	Sell	-320	Closed	-$576K	–	251
2015 Q2	$576K	Buy	+320	New	+$576K	0.17%	139